European Hematology Association

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia2 trials
• Childhood cancers2 trials
• Multiple myeloma1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting3 trials

Lead sponsor

• Children's Oncology Group1 trial
• Martin Schrappe1 trial
• Stichting European Myeloma Network1 trial

Running trials

• Active, not recruiting

  Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma

  NCT03710603· Phase 3· Stichting European Myeloma Network· Source

• Recruiting

  Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

  NCT03643276· Phase 3· Martin Schrappe· Source

• Active, not recruiting

  Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

  NCT03007147· Phase 3· Children's Oncology Group· Source